Learning from 7 Years of Experience with Sorafenib in Advanced HCC: Sorafenib Better than Sorafenib?
- 368 Downloads
KeywordsSorafenib Sunitinib Overall Response Rate Sorafenib Treatment Adverse Event Management
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Compliance with Ethical Standards
Conflict of Interest
Sandrine Faivre, Armand de Gramont and Eric Raymond declare no conflicts of interest.
- 7.Marrero JA, Lencioni R, Ye S-L, et al. Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sor-treated patients (pts): Clinical findings in pts with liver dysfunction [abstract no. 4126]. J Clin Oncol 2013;(Suppl)Google Scholar
- 10.Azad NS, Aragon-Ching JB, Dahut WL, et al. Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vegf therapy. Clin Cancer Res 2009;15:1411–6.Google Scholar
© Springer International Publishing Switzerland 2016